World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
52
Citations
9997
World Ranking
4199
National Ranking
97

Overview

Mark E. Jones is affiliated with Basilea Pharmaceutica in Switzerland. Their research spans multiple domains within biochemistry, genetics, and molecular biology, with a particular emphasis on genomics and phylogenetic studies. Their work addresses key topics such as genetic diversity and population structure, bioinformatics and genomic networks, and genome rearrangement algorithms.

The scientist has produced a substantial body of work that contributes to both theoretical and applied aspects of molecular biology and genetics. The following topics characterize their primary research interests:

  • Genomics and Phylogenetic Studies
  • Genetic diversity and population structure
  • Bioinformatics and Genomic Networks
  • Evolution and Paleontology Studies
  • Genome Rearrangement Algorithms
  • Plant and animal studies
  • Algorithms and Data Compression

Jones has collaborated frequently with several researchers, highlighting active partnerships in their scientific pursuits. Frequent co-authors include:

  • Leo van Iersel
  • Yukihiro Murakami
  • Remie Janssen
  • Norbert Zeh
  • Katharina T. Huber

Their academic output has appeared in various publication venues, including:

  • arXiv (Cornell University)
  • Algorithmica
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Computer and System Sciences
  • SSRN Electronic Journal

Recent significant publications by Mark E. Jones include:

  • "Distinguishing level-1 phylogenetic networks on the basis of data generated by Markov processes," 2021, Journal of Mathematical Biology
  • "Orchard Networks are Trees with Additional Horizontal Arcs," 2022, Bulletin of Mathematical Biology
  • "A Practical Fixed-Parameter Algorithm for Constructing Tree-Child Networks from Multiple Binary Trees," 2022, Algorithmica
  • "A unifying characterization of tree-based networks and orchard networks using cherry covers," 2021, Data Archiving and Networked Services (DANS)
  • "Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia," 2023, Antibiotics

The integration of computational methods and biological principles features prominently within Jones's work, intersecting with subfields such as molecular biology, genetics, paleontology, ecology, evolution, behavior, systematics, and artificial intelligence. This cross-disciplinary range supports advancements in understanding evolutionary patterns, genetic networks, and algorithmic approaches to biological data.

Best Publications

  • Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States

    James A. Karlowsky;Laurie J. Kelly;Clyde Thornsberry;Mark E. Jones

  • Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

    James A. Karlowsky;Deborah C. Draghi;Mark E. Jones;Clyde Thornsberry

  • Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998.

    Ad C. Fluit;Mark E. Jones;Franz-Josef Schmitz;Jacques Acar

  • Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.

    Clyde Thornsberry;Mark E. Jones;Mary L. Hickey;Yolanda Mauriz

  • Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.

    Daniel F. Sahm;Clyde Thornsberry;David C. Mayfield;Mark E. Jones

  • Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American Surveillance study (2000–2002)

    Mark E Jones;Deborah C Draghi;Clyde Thornsberry;James A Karlowsky

  • Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds.

    P. Martinez-Freijo;A. C. Fluit;F.-J. Schmitz;V. S. C. Grek

  • Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999–2000

    Clyde Thornsberry;Daniel F. Sahm;Laurie J. Kelly;Ian A. Critchley

  • Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy.

    Mark E. Jones;James A. Karlowsky;Deborah C. Draghi;Clyde Thornsberry

  • The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.

    Franz-Josef Schmitz;Ad C. Fluit;Mechthild Gondolf;Ralf Beyrau

  • Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002

    James A Karlowsky;Mark E Jones;Deborah C Draghi;Clyde Thornsberry

  • Factors Associated with Relative Rates of Antimicrobial Resistance among Streptococcus pneumoniae in the United States: Results from the TRUST Surveillance Program (1998–2002)

    James A. Karlowsky;Clyde Thornsberry;Mark E. Jones;Alan T. Evangelista

  • The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.

    Franz-Josef Schmitz;Ad C. Fluit;Marc Lückefahr;Beate Engler

  • Prevalence of gyrA, gyrB, parC, and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory Season

    Mark E. Jones;Daniel F. Sahm;Nele Martin;Sibylle Scheuring

  • Trends in Antimicrobial Susceptibilities among Enterobacteriaceae Isolated from Hospitalized Patients in the United States from 1998 to 2001

    James A. Karlowsky;Mark E. Jones;Clyde Thornsberry;Ian R. Friedland

  • Characterization of grlA,grlB, gyrA, and gyrB Mutations in 116 Unrelated Isolates of Staphylococcus aureus and Effects of Mutations on Ciprofloxacin MIC

    Franz-Josef Schmitz;Mark E. Jones;Basia Hofmann;Birgit Hansen

  • Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002.

    Robert K. Flamm;Mellany K. Weaver;Clyde Thornsberry;Mark E. Jones

  • Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis

    Daniel F. Sahm;James A. Karlowsky;Laurie J. Kelly;Ian A. Critchley

  • Emergence and Spread in French Hospitals of Methicillin-Resistant Staphylococcus aureus with Increasing Susceptibility to Gentamicin and Other Antibiotics

    Hervé Lelièvre;Gerard Lina;Mark E. Jones;Claude Olive

  • Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000–2001

    Ian A Critchley;Deborah C Draghi;Daniel F Sahm;Clyde Thornsberry

  • Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the

    James A. Karlowsky;Laurie J. Kelly;Clyde Thornsberry;Mark E. Jones

  • Original articles Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds

    P. Martinez-Freijo;A. C. Fluit;V. S. C. Grek;J. Verhoef

Frequent Co-Authors

Clyde Thornsberry
Clyde Thornsberry Centers for Disease Control and Prevention
James A. Karlowsky
James A. Karlowsky University of Manitoba
Ian A. Critchley
Ian A. Critchley Spero Therapeutics (United States)
Ad C. Fluit
Ad C. Fluit Utrecht University
Helio S. Sader
Helio S. Sader JMI Laboratories
Jan Verhoef
Jan Verhoef Utrecht University
François Vandenesch
François Vandenesch Claude Bernard University Lyon 1
Jerome Etienne
Jerome Etienne Claude Bernard University Lyon 1
James O. Kahn
James O. Kahn Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology in the USA opens doors to various career paths, many of which intersect with health sciences and technology fields. For example, professionals interested in patient-centered care might explore programs like functional medicine np programs, which blend traditional nursing expertise with holistic health approaches.

Alternatively, those drawn to the administrative side of healthcare may consider roles in health information management. This growing field offers promising opportunities, detailed in the health information management job description and salary insights, showcasing its importance in managing patient data and improving healthcare delivery.

To get started, students should seek accredited online health information management degree cahiim programs that meet industry standards and prepare graduates for certification.

Moreover, the role of coding within healthcare is critical for accurate billing and records. Exploring the certified professional coder salary landscape can provide insight into the financial and professional benefits of this career path.

Best Scientists Citing Mark E. Jones

Trending Scientists

Recently Published Articles